• PMID: 16128988
• Gene Name: CFTR
• Condition: Male infertility
• Association: The results of our study showed no statistical difference between CFTR carrier frequency in the infertile and fertile population. Specifically, the IVS8-6(5T) allele carrier frequency was similar in NOb infertile patients when compared with fertile men, b
• Mutation: IVS8-6(5T) allele
• Population size: 170
• Population details: 170 (83 non-obstructive (NOb) infertility, 87 clinically well-defined fertile individuals as controls)
• Sex: Male
• Infertility type: Male infertility
• Other associated phenotypes: Male infertility

Molecular evaluation of CFTR sequence variants in male infertility of testicular origin

Larriba S, Bonache S, Sarquella J, Ramos MD, Giménez J, Bassas L, Casals T.

Although the involvement of the CFTR gene has been well established in congenital agenesia of vas deferens, its role in non-obstructive (NOb) infertility is still a matter of debate. In order to definitively define the involvement of the CFTR gene in spermatogenic impairment and a potential synergistic contribution to known genetic and clinical factors, genetic variants in the entire coding sequence and the immediately flanking regions of the CFTR gene, along with a thorough clinical evaluation, were analysed in 83 NOb infertile patients and 87 clinically well-defined fertile individuals as controls. The results of our study showed no statistical difference between CFTR carrier frequency in the infertile and fertile population. Specifically, the IVS8-6(5T) allele carrier frequency was similar in NOb infertile patients when compared with fertile men, but it is noteworthy that, when fertile men were classified into having optimal and suboptimal fertility, no 5T allele was found among the 35 men with optimal fertility parameters. In conclusion, extensive CFTR analysis in infertile individuals and fertile population as adequate control definitively excludes the involvement of the CFTR gene variants in sperm production and stresses the importance of carefully identifying those individuals with obstructive defects, in whom CFTR screening will be beneficial. FAU - Larriba, S AU - Larriba S AD - Medical and Molecular Genetics Center-IRO-IDIBELL, Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Spain. slarriba@iro.es FAU - Bonache, S AU - Bonache S FAU - Sarquella, J AU - Sarquella J FAU - Ramos, M D AU - Ramos MD FAU - Giménez, J AU - Giménez J FAU - Bassas, L AU - Bassas L